Esperion Therapeutics
ESPR
#6514
Rank
C$1.17 B
Marketcap
C$4.56
Share price
0.00%
Change (1 day)
33.57%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Last known market cap: C$1.17 Billion

As of November 2026 Esperion Therapeutics has a market cap of C$1.17 Billion. This makes Esperion Therapeutics the world's 6514th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$1.17 B-10.45%
2025C$1.31 B103.46%
2024C$0.64 B42.94%
2023C$0.45 B-27.6%
2022C$0.62 B60.52%
2021C$0.38 B-54.83%
2020C$0.85 B-59.88%
2019C$2.14 B27.41%
2018C$1.68 B-22.49%
2017C$2.16 B471.48%
2016C$0.37 B-45.42%
2015C$0.69 B-27.17%
2014C$0.95 B325.49%
2013C$0.22 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$225.55 B 19,104.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$136.86 B 11,552.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$2.43 B 107.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C$0.98 B-15.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$6.52 B 455.22%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$16.81 B 1,331.44%๐Ÿ‡บ๐Ÿ‡ธ USA